Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system
- PMID: 28186159
- PMCID: PMC5301229
- DOI: 10.1038/srep42325
Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system
Abstract
Kampo is the general designation for traditional Japanese herbal medicines, which are recognized as official medicines and listed in the Japanese pharmacopoeia (JP). In most cases, it is difficult to identify the crude drug materials to species level using only traditional identification methods. We report the first online DNA barcode identification system, which includes standard barcode sequences from approximately 95% of the species recorded in the JP (16th edition). This tool provides users with basic information on each crude drug recorded in the JP, DNA barcoding identification of herbal material, and the standard operating procedure (SOP) from sampling to data analysis. ITS2 sequences (psbA-trnH was an alternative when ITS2 could not be amplified) were generated from a total of 576 samples to establish the database. An additional 100 samples (from different medicinal parts, from both single origin and multiple origins and from both retailers and the planting base) were identified using the system. A total of 78% of the test samples were identified as the species listed on their label. This system establishes a model platform for other pharmacopeias from countries like China, Korea, the US and the European Union, for the safe and effective utilization of traditional herbal medicines.
Conflict of interest statement
The authors declare no competing financial interests.
References
-
- Motoo Y., Arai I., Hyodo I. & Tsutani K. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines. Complement. Ther. Med. 17, 147–154 (2009). - PubMed
-
- Efferth T., Miyachi H. & Bartsch H. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy. Cancer Genomics Proteomics 4, 81–91 (2007). - PubMed
-
- Ikegami F., Fujii Y. & Satoh T. Toxicological considerations of Kampo medicines in clinical use. Toxicology 198, 221–228 (2004). - PubMed
-
- Ikegami F., Sumino M., Fujii Y., Akiba T. & Satoh T. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum. Exp. Toxicol. 25, 481–494 (2006). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
